UiPath

UiPath reported Q2 FY2027 results above guidance with ARR of $1.938 billion (up 12%), revenue of $410 million (up 13%) and non-GAAP operating income of $89 million, prompting management to raise its fiscal 2027 revenue and operating income targets. Adjusted free cash flow fell to $31 million, driven mainly by tax timing, while customer growth concentrated in large accounts and dollar-based net retention rose to 109%. Despite stronger fundamentals, the stock dropped after investors questioned whether advancing AI models could displace workflow automation; management said AI augments orchestration but provided no AI-specific ARR figures. Investor Day on September 22 and ARR guidance for October 31 will be key tests of UiPath's AI monetization and growth outlook. » More on finance.yahoo.com

The iShares Expanded Tech-Software Sector ETF fell about 1.8% in the afternoon, weighed down by negative analyst comments on core holdings such as UiPath and Pegasystems. Although some analysts raised price targets for UiPath, none upgraded the stock to "buy," which traders took as a sign the rally might be overstretched. Pegasystems came under additional pressure after signs of slowing growth in annual contract value and management comments pointing to customer caution related to AI. Weak overall market performance amplified the decline, with IGV sliding as low as $102.08. » More on de.investing.com

UiPath shares fell about 7% after four analysts raised price targets but maintained Hold or Underperform ratings, signaling the recent rally outpaced fundamentals. The company reported fiscal Q2 revenue of $410.3 million, ARR of $1.938 billion (up 12% YoY) and returned to GAAP operating income of $32 million. Pegasystems declined roughly 6–7% in sympathy, while C3.ai held up better amid its own turnaround narrative. UiPath’s investor day on September 22 is the next key catalyst for evidence that AI attach rates will drive meaningful ARR acceleration. » More on finance.yahoo.com